Lawrence J Hineline Net Worth & Insider Trades

Lawrence J Hineline - SVP Finance CFO, Intra-Cellular Therapies, Inc

As of September 23, 2022

What is Lawrence J Hineline's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's SVP Finance CFO, Lawrence J Hineline, is estimated to be about $25.28M . Lawrence J Hineline owns about 0 unit of Intra-Cellular Therapies, Inc common stock. In the last 8 years at Intra-Cellular Therapies, Inc, Lawrence J Hineline has sold an estimated value of $22.98M worth.

What is Lawrence J Hineline's Past Insider Trading?

Lawrence J Hineline's largest purchase order was 175,000 units , worth over $2.94M on December 23, 2021. Lawrence J Hineline's largest sale order was 175,000 units , worth over $8.33M on December 23, 2021. In total, Lawrence J Hineline has made about 33 transactions over 8 years of their time at Intra-Cellular Therapies, Inc. Lawrence J Hineline usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 65,164 units , worth over $2.97M on September 23, 2022.

Lawrence J Hineline

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Lawrence J Hineline's Salary in 2020?

As SVP Finance CFO of Intra-Cellular Therapies, Inc, Lawrence J Hineline has a total base salary of $463,400 . Lawrence J Hineline received compensation valued at about $2,206,183 in 2020 after becoming SVP Finance CFO. The vast majority of their compensation came in the form of a bonus of $222,432 , stock awards of $1,049,984 , option awards of $449,993 , and other compensation of $20,374 .

What is Lawrence J Hineline's' Mailing Address?

  • Mailing address is C/o Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 NY

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on December 2, 2022 by Michael Halstead who sold 50,000 units worth $2.69M . In the last 8 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $105.92M and bought an estimated value of $63.6M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1